Why These 5 Stocks Were in the Spotlight This Week

4. Moderna, Inc. (NASDAQ:MRNA) trended this week due to the Merck news. The company also trended due to a Bloomberg article that said the FDA is leaning towards authorizing a half dose booster shot of Moderna, Inc. (NASDAQ:MRNA)’s COVID-19 vaccine. 37  elite funds we track were long Moderna, Inc. (NASDAQ:MRNA) at the end of the second quarter, down 2 from the prior quarter.